Association of immune-related adverse events (irAEs) with clinical benefit in patients with metastatic urothelial carcinoma (mUC) treated with immune-checkpoint inhibitors (ICIs).

被引：0
|
作者：
Vitale, Nuzzo Pier
Pond, Gregory Russell
Abou Alaiwi, Sarah
Nassar, Amin
Flippot, Ronan
Choueiri, Toni K.
Harshman, Lauren Christine
Sonpavde, Guru
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] McMaster Univ, Dept Oncol, Hamilton, ON, Canada
[3] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[4] Hop Piti Salpetriere, Lab Avec Fdn, Paris, France
[5] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA
[6] Harvard Med Sch, Boston, MA 02115 USA
[7] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16038
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    del Carpio, L. P.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruella, M.
    ANNALS OF ONCOLOGY, 2018, 29 : 509 - 509
  • [2] Frequency of delayed immune-related adverse events (irAEs) in hospitalized patients treated with immune checkpoint inhibitors (ICIs)
    Durbin, Sienna
    Zubiri, Leyre
    Perlman, Katherine
    Molina, Gabriel
    Jacoby, Ted
    Shah, Nishi
    Reynolds, Kerry Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Early incidence of immune-related adverse events (irAEs) predicts efficacy in patients (pts) with solid tumors treated with immune-checkpoint inhibitors (ICIs).
    Morehouse, Chris
    Abdullah, Shaad Essa
    Gao, Chen
    Dar, Mohammed M.
    Ranade, Koustubh
    Higgs, Brandon W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Impact of immune-related adverse events on survival in patients with metastastic urothelial carcinoma treated with immune-checkpoint inhibitors.
    Morales-Barrera, Rafael
    Suarez Rodriguez, Cristina
    Gonzalez, Macarena
    Ros, Javier
    Eugenia Semidey, Maria
    Hernandez, Ester Serra
    Mateo, Joaquin
    Saez, Carlos Fernandez
    Lozano, Fernando
    Mast, Richard
    Roche, Sarai
    Quintana, Angela
    Gutierrez Fernandez, Sara
    Serrano, Cesar
    Valverde, Claudia
    de Torres, Ines
    Maldonado, Xavier
    Morote, Juan
    Carles, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [6] Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
    Reyes, Kevin R.
    Zhang, Li
    Zhu, Xiaolin
    Jindal, Tanya
    Deshmukh, Prianka
    de Kouchkovsky, Ivan
    Kumar, Vipul
    Maldonado, Edward
    Kwon, Daniel H.
    Chan, Emily
    Porten, Sima P.
    Borno, Hala
    Bose, Rohit
    Desai, Arpita
    Aggarwal, Rahul Raj
    Small, Eric Jay
    Fong, Lawrence
    Chou, Jonathan
    Friedlander, Terence W.
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] Immune checkpoint inhibitors (ICIs) in gastrointestinal (GI) cancer: Immune-related adverse events (IRAEs) and efficacy.
    Das, Satya
    Ciombor, Kristen Keon
    Haraldsdottir, Sigurdis
    Pumpalova, Yoanna S.
    Sahin, Ibrahim Halil
    Shyr, Yu
    Chu, Shih-Kai
    Lin, Emily Pei-Ying
    Hsu, Chih-Yuan
    Goff, Laura Williams
    Cardin, Dana Backlund
    Bilen, Mehmet Asim
    Berlin, Jordan
    Wu, Christina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Martini, Dylan J.
    Goyal, Subir
    Liu, Yuan
    Evans, Sean T.
    Olsen, T. Anders
    Case, Katherine
    Magod, Benjamin L.
    Brown, Jacqueline T.
    Yantorni, Lauren
    Russler, Greta Anne
    Caulfield, Sarah
    Goldman, Jamie M.
    Nazha, Bassel
    Harris, Wayne B.
    Kissick, Haydn T.
    Master, Viraj A.
    Kucuk, Omer
    Carthon, Bradley C.
    Bilen, Mehmet Asim
    ONCOLOGIST, 2021, 26 (10): : E1742 - E1750
  • [9] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Jingting Wang
    Yan Ma
    Haishan Lin
    Jing Wang
    Bangwei Cao
    BMC Immunology, 25
  • [10] Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
    Wang, Jingting
    Ma, Yan
    Lin, Haishan
    Wang, Jing
    Cao, Bangwei
    BMC IMMUNOLOGY, 2024, 25 (01)
12345